Moreover, adiponectin was found to modulate dendritic cells (DCs) by enhancing immunosuppressive signaling, promoting regulatory T cell (Treg) expansion, and inhibiting antigen-specific T cell responses, resulting in tumor immune escape (48, 49). Here, ADIPOQ is linked to neoplasm.